NPI 1497227078: Open Payments
NPI 1497227078. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 10 payments from 6 companies in 2025. Trend: 2023 $559 · 2024 $0 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $108 |
| Endologix LLC | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: VERQUVO, Torus Stent Graft System, Flexitouch Plus, REPATHA, Wegovy, LEQVIO.
